APG808 resulted in a rapid and durable decrease from baseline in FeNO and pSTAT6 measurements throughout the 12 weeks.

The U.S. prescribing information for AIRSUPRA now includes results from the Phase IIIb BATURA trial, which demonstrated that the medication significantly reduced severe asthma exacerbations in ...

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

Questions remain on whether there are links between patients with asthma and RA, including heterogeneity of disease.

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to ...

If you are wheezing, coughing, or having extreme shortness of breath, you may be having an asthma attack.

If you live with mild to moderate environmental allergies, you may be able to treat them with immunotherapy — and you can ...

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory ...

Researchers say the findings, published today in The Lancet, provide the evidence needed to bring children’s global asthma guidelines into line with adults’, which could benefit millions of children ...

Research shows asthma and multi-food allergies elevate the odds of reactions in oral food challenges, emphasizing the ...

Interferon lambda concentrations in nasal lining fluid fell in or above the predicted therapeutic range with a nasally ...